US 7728148
Acyclic oximyl hepatitis C protease inhibitors
granted A61KA61K38/00A61P
Quick answer
US patent 7728148 (Acyclic oximyl hepatitis C protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K38/00, A61P, A61P31/12